Early conversion to a CNI-free immunosuppression with SRL after renal transplantation-Long-term follow-up of a multicenter trial.
<h4>Introduction</h4>Early conversion to a CNI-free immunosuppression with SRL was associated with an improved 1- and 3- yr renal function as compared with a CsA-based regimen in the SMART-Trial. Mixed results were reported on the occurrence of donor specific antibodies under mTOR-Is. He...
Main Authors: | Joachim Andrassy, Markus Guba, Antje Habicht, Michael Fischereder, Johann Pratschke, Andreas Pascher, Katharina M Heller, Bernhard Banas, Oliver Hakenberg, Thomas Vogel, Bruno Meiser, Andrea Dick, Jens Werner, Teresa Kauke, SMART-Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0234396 |
Similar Items
-
Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
by: Teresa Kauke, et al.
Published: (2016-01-01) -
Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months.
by: Sebastian Wolf, et al.
Published: (2018-01-01) -
Influence of Belatacept- vs. CNI-Based Immunosuppression on Vascular Stiffness and Body Composition
by: Zbigniew Heleniak, et al.
Published: (2022-02-01) -
UUM CNY Carnival
by: Kwong Wah, Yit Poh
Published: (2013) -
Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.
by: Flechner, S, et al.
Published: (2005)